Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
Immunological Reviews
|
December 1, 1996
The HLA likes and dislikes of allospecific and non-MHC-restricted cytotoxic T lymphocytes
E Nössner, C S Falk, P Jantzer, et al.
Human Immunology
|
December 1, 1993
Microheterogeneity in HLA-B35 alleles influences peptide-dependent allorecognition by cytotoxic T cells but not binding of a peptide-restricted monoclonal antibody
A Steinle, C Reinhardt, E Nössner, et al.
Lancet (London, England)
|
April 21, 1984
Rare variant of complement C4 is seen in high frequency in patients with primary glomerulonephritis
R Wank, D J Schendel, G J O'Neill, et al.
Nature Medicine
|
October 9, 2001
Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay
C Becker, H Pohla, B Frankenberger, et al.
Vox Sanguinis
|
January 1, 1988
Major histocompatibility complex markers in patients with nomifensine-induced immune hemolytic anemia
G Mueller-Eckhardt, G Giers, A Salama, et al.
Diabetologia
|
February 24, 2001
HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex
C Huck, J Endl, T Walk, et al.
Human Gene Therapy
|
May 15, 1998
Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo
W Uckert, T Kammertöns, K Haack, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 15, 1993
Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines
D J Schendel, B Gansbacher, R Oberneder, et al.
Oncogene
|
November 2, 2005
GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing
R Djafarzadeh, E Noessner, H Engelmann, et al.
The Journal of Experimental Medicine
|
May 1, 1973
Cell-mediated lympholysis. Importance of serologically defined H-2 regions
B J Alter, D J Schendel, M L Bach, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
Immunological Reviews
|
December 1, 1996
The HLA likes and dislikes of allospecific and non-MHC-restricted cytotoxic T lymphocytes
E Nössner, C S Falk, P Jantzer, et al.
Human Immunology
|
December 1, 1993
Microheterogeneity in HLA-B35 alleles influences peptide-dependent allorecognition by cytotoxic T cells but not binding of a peptide-restricted monoclonal antibody
A Steinle, C Reinhardt, E Nössner, et al.
Lancet (London, England)
|
April 21, 1984
Rare variant of complement C4 is seen in high frequency in patients with primary glomerulonephritis
R Wank, D J Schendel, G J O'Neill, et al.
Nature Medicine
|
October 9, 2001
Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay
C Becker, H Pohla, B Frankenberger, et al.
Vox Sanguinis
|
January 1, 1988
Major histocompatibility complex markers in patients with nomifensine-induced immune hemolytic anemia
G Mueller-Eckhardt, G Giers, A Salama, et al.
Diabetologia
|
February 24, 2001
HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex
C Huck, J Endl, T Walk, et al.
Human Gene Therapy
|
May 15, 1998
Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo
W Uckert, T Kammertöns, K Haack, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 15, 1993
Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines
D J Schendel, B Gansbacher, R Oberneder, et al.
Oncogene
|
November 2, 2005
GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing
R Djafarzadeh, E Noessner, H Engelmann, et al.
The Journal of Experimental Medicine
|
May 1, 1973
Cell-mediated lympholysis. Importance of serologically defined H-2 regions
B J Alter, D J Schendel, M L Bach, et al.
Page
of 9